Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway

doi:10.4251/wjgo.v16.i7.3211

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (135)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-8)

Tables (1-1)

Sum=125

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=5

Jul 15, 2024 (publication date) through Jul 16, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3211-3229
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3211

Full Size Figure Download Figure

Figure 8 A schematic model of the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 pathway in gastric intestinal metaplasia cells and the mechanism of Weiwei Decoction in the treatment of gastric intestinal metaplasia through this pathway. OLFM4: Olfactomedin 4; NOD1: Nucleotide-binding oligomerization domain 1; CDX2: Caudal-type homeobox gene 2; VIL1: Villin 1; KLF4: KLF transcription factor 4; WWD: Weiwei Decoction; MUC2: MUCIN 2.

Citation: Zhou DS, Zhang WJ, Song SY, Hong XX, Yang WQ, Li JJ, Xu JQ, Kang JY, Cai TT, Xu YF, Guo SJ, Pan HF, Li HW. Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway. World J Gastrointest Oncol 2024; 16(7): 3211-3229
URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3211.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3211